selected publications
-
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response.
Blood.
2025
Academic Article
GET IT
Times cited: 3 - Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma. 2024 GET IT
-
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.
Cancer immunology research.
2024
Academic Article
GET IT
Times cited: 3 -
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2023
Academic Article
GET IT
Times cited: 7 -
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
Journal for immunotherapy of cancer.
2023
Academic Article
GET IT
Times cited: 9 -
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
2022
GET IT
Times cited: 11 -
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
Immunity.
2022
Academic Article
GET IT
Times cited: 97 -
PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.
Blood.
2019
Academic Article
GET IT
Times cited: 93